These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1279 related articles for article (PubMed ID: 33215344)

  • 21. A phase II trial of accelerated radiotherapy using weekly stereotactic conformal boost for supratentorial glioblastoma multiforme: RTOG 0023.
    Cardinale R; Won M; Choucair A; Gillin M; Chakravarti A; Schultz C; Souhami L; Chen A; Pham H; Mehta M
    Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1422-8. PubMed ID: 16750317
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of single brain metastasis: a practice guideline.
    Mintz A; Perry J; Spithoff K; Chambers A; Laperriere N
    Curr Oncol; 2007 Aug; 14(4):131-43. PubMed ID: 17710205
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radiotherapy of high-grade gliomas: current standards and new concepts, innovations in imaging and radiotherapy, and new therapeutic approaches.
    Dhermain F
    Chin J Cancer; 2014 Jan; 33(1):16-24. PubMed ID: 24384237
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radiation therapy for glioblastoma: Executive summary of an American Society for Radiation Oncology Evidence-Based Clinical Practice Guideline.
    Cabrera AR; Kirkpatrick JP; Fiveash JB; Shih HA; Koay EJ; Lutz S; Petit J; Chao ST; Brown PD; Vogelbaum M; Reardon DA; Chakravarti A; Wen PY; Chang E
    Pract Radiat Oncol; 2016; 6(4):217-225. PubMed ID: 27211230
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for malignant glioma.
    Tsao MN; Mehta MP; Whelan TJ; Morris DE; Hayman JA; Flickinger JC; Mills M; Rogers CL; Souhami L
    Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):47-55. PubMed ID: 16111571
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phase 2 trial of hypofractionated high-dose intensity modulated radiation therapy with concurrent and adjuvant temozolomide for newly diagnosed glioblastoma.
    Iuchi T; Hatano K; Kodama T; Sakaida T; Yokoi S; Kawasaki K; Hasegawa Y; Hara R
    Int J Radiat Oncol Biol Phys; 2014 Mar; 88(4):793-800. PubMed ID: 24495592
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of imaging for the management of newly diagnosed glioblastoma in adults: a systematic review and evidence-based clinical practice guideline update.
    Lundy P; Domino J; Ryken T; Fouke S; McCracken DJ; Ormond DR; Olson JJ
    J Neurooncol; 2020 Nov; 150(2):95-120. PubMed ID: 33215340
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A phase I dose escalation study of hypofractionated IMRT field-in-field boost for newly diagnosed glioblastoma multiforme.
    Monjazeb AM; Ayala D; Jensen C; Case LD; Bourland JD; Ellis TL; McMullen KP; Chan MD; Tatter SB; Lesser GJ; Shaw EG
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):743-8. PubMed ID: 21236604
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phase I study to determine the maximum-tolerated dose of radiation in standard daily and hyperfractionated-accelerated twice-daily radiation schedules with concurrent chemotherapy for limited-stage small-cell lung cancer.
    Choi NC; Herndon JE; Rosenman J; Carey RW; Chung CT; Bernard S; Leone L; Seagren S; Green M
    J Clin Oncol; 1998 Nov; 16(11):3528-36. PubMed ID: 9817271
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phase I three-dimensional conformal radiation dose escalation study in newly diagnosed glioblastoma: Radiation Therapy Oncology Group Trial 98-03.
    Tsien C; Moughan J; Michalski JM; Gilbert MR; Purdy J; Simpson J; Kresel JJ; Curran WJ; Diaz A; Mehta MP;
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):699-708. PubMed ID: 18723297
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phase II trial of hypofractionated IMRT with temozolomide for patients with newly diagnosed glioblastoma multiforme.
    Reddy K; Damek D; Gaspar LE; Ney D; Waziri A; Lillehei K; Stuhr K; Kavanagh BD; Chen C
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):655-60. PubMed ID: 22483738
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prolonged survival for patients with newly diagnosed, inoperable glioblastoma with 3-times daily ultrafractionated radiation therapy.
    Beauchesne P; Bernier V; Carnin C; Taillandier L; Djabri M; Martin L; Michel X; Maire JP; Khalil T; Kerr C; Gorlia T; Stupp R; Pedeux R
    Neuro Oncol; 2010 Jun; 12(6):595-602. PubMed ID: 20511183
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A phase I dose escalation study of hypofractionated stereotactic radiotherapy as salvage therapy for persistent or recurrent malignant glioma.
    Hudes RS; Corn BW; Werner-Wasik M; Andrews D; Rosenstock J; Thoron L; Downes B; Curran WJ
    Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):293-8. PubMed ID: 10030252
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radiotherapy for newly diagnosed malignant glioma in adults: a systematic review.
    Laperriere N; Zuraw L; Cairncross G;
    Radiother Oncol; 2002 Sep; 64(3):259-73. PubMed ID: 12242114
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phase II, two-arm RTOG trial (94-11) of bischloroethyl-nitrosourea plus accelerated hyperfractionated radiotherapy (64.0 or 70.4 Gy) based on tumor volume (> 20 or < or = 20 cm(2), respectively) in the treatment of newly-diagnosed radiosurgery-ineligible glioblastoma multiforme patients.
    Coughlin C; Scott C; Langer C; Coia L; Curran W; Rubin P
    Int J Radiat Oncol Biol Phys; 2000 Dec; 48(5):1351-8. PubMed ID: 11121633
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treating Glioblastoma Multiforme (GBM) with super hyperfractionated radiation therapy: Implication of temporal dose fractionation optimization including cancer stem cell dynamics.
    Yu VY; Nguyen D; O'Connor D; Ruan D; Kaprealian T; Chin R; Sheng K
    PLoS One; 2021; 16(2):e0245676. PubMed ID: 33524046
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1.
    Lunsford LD; Flickinger JC; Larson D
    Oncologist; 1997; 2(1):59-61. PubMed ID: 10388030
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic factors in glioblastoma multiforme. 10 years experience of a single institution.
    Hulshof MC; Koot RW; Schimmel EC; Dekker F; Bosch DA; González González D
    Strahlenther Onkol; 2001 Jun; 177(6):283-90. PubMed ID: 11446316
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of surgical resection in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline.
    Kalkanis SN; Kondziolka D; Gaspar LE; Burri SH; Asher AL; Cobbs CS; Ammirati M; Robinson PD; Andrews DW; Loeffler JS; McDermott M; Mehta MP; Mikkelsen T; Olson JJ; Paleologos NA; Patchell RA; Ryken TC; Linskey ME
    J Neurooncol; 2010 Jan; 96(1):33-43. PubMed ID: 19960230
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Congress of Neurological Surgeons systematic review and evidence-based guidelines update on the role of targeted therapies and immunotherapies in the management of progressive glioblastoma.
    Winograd E; Germano I; Wen P; Olson JJ; Ormond DR
    J Neurooncol; 2022 Jun; 158(2):265-321. PubMed ID: 34694567
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 64.